LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Rif, Maria"
  2. AU="Chamakuri, Srinivas"
  3. AU=Oswin Henry P AU=Oswin Henry P
  4. AU=Sandvig Kirsten AU=Sandvig Kirsten
  5. AU="Mohanaruban, Aruchuna"
  6. AU="McDowell, Cliona"
  7. AU="Boehncke, Heiner"
  8. AU=Chan Rebecca J
  9. AU="Glare, T.R."
  10. AU="Dubose, Thomas D"
  11. AU="Hirano, Toru"
  12. AU="Kong, Rebekah"
  13. AU="Karen de Jager"
  14. AU=Peters A
  15. AU="Xiaofang Li"
  16. AU="Campbell, John D"
  17. AU="Emara, Yasmine"
  18. AU="Orbe, Paul"
  19. AU="Karel J van Erpecum"
  20. AU=Oltean Mihai
  21. AU="Relph, Katharine A"
  22. AU=Li Jifen AU=Li Jifen
  23. AU="Diamant, Eran"
  24. AU="Kyoung, Henry" AU="Kyoung, Henry"
  25. AU=al-Gazali L I
  26. AU="Maillet, Jean-Michel"
  27. AU="Enlong Liu"
  28. AU="Afria, Dikshant"
  29. AU="Duggal, M. S."
  30. AU="Narcisa G. Pricope"
  31. AU="Kunisada, Toshiyuki"
  32. AU="Barvkar, Vitthal"

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup.

Ghannoum, Marc / Gosselin, Sophie / Hoffman, Robert S / Lavergne, Valery / Mégarbane, Bruno / Hassanian-Moghaddam, Hossein / Rif, Maria / Kallab, Siba / Bird, Steven / Wood, David M / Roberts, Darren M

Critical care (London, England)

2023  Band 27, Heft 1, Seite(n) 56

Abstract: Ethylene glycol (EG) is metabolized into glycolate and oxalate and may cause metabolic acidemia, neurotoxicity, acute kidney injury (AKI), and death. Historically, treatment of EG toxicity included supportive care, correction of acid-base disturbances ... ...

Abstract Ethylene glycol (EG) is metabolized into glycolate and oxalate and may cause metabolic acidemia, neurotoxicity, acute kidney injury (AKI), and death. Historically, treatment of EG toxicity included supportive care, correction of acid-base disturbances and antidotes (ethanol or fomepizole), and extracorporeal treatments (ECTRs), such as hemodialysis. With the wider availability of fomepizole, the indications for ECTRs in EG poisoning are debated. We conducted systematic reviews of the literature following published EXTRIP methods to determine the utility of ECTRs in the management of EG toxicity. The quality of the evidence and the strength of recommendations, either strong ("we recommend") or weak/conditional ("we suggest"), were graded according to the GRADE approach. A total of 226 articles met inclusion criteria. EG was assessed as dialyzable by intermittent hemodialysis (level of evidence = B) as was glycolate (Level of evidence = C). Clinical data were available for analysis on 446 patients, in whom overall mortality was 18.7%. In the subgroup of patients with a glycolate concentration ≤ 12 mmol/L (or anion gap ≤ 28 mmol/L), mortality was 3.6%; in this subgroup, outcomes in patients receiving ECTR were not better than in those who did not receive ECTR. The EXTRIP workgroup made the following recommendations for the use of ECTR in addition to supportive care over supportive care alone in the management of EG poisoning (very low quality of evidence for all recommendations): i) Suggest ECTR if fomepizole is used and EG concentration > 50 mmol/L OR osmol gap > 50; or ii) Recommend ECTR if ethanol is used and EG concentration > 50 mmol/L OR osmol gap > 50; or iii) Recommend ECTR if glycolate concentration is > 12 mmol/L or anion gap > 27 mmol/L; or iv) Suggest ECTR if glycolate concentration 8-12 mmol/L or anion gap 23-27 mmol/L; or v) Recommend ECTR if there are severe clinical features (coma, seizures, or AKI). In most settings, the workgroup recommends using intermittent hemodialysis over other ECTRs. If intermittent hemodialysis is not available, CKRT is recommended over other types of ECTR. Cessation of ECTR is recommended once the anion gap is < 18 mmol/L or suggested if EG concentration is < 4 mmol/L. The dosage of antidotes (fomepizole or ethanol) needs to be adjusted during ECTR.
Mesh-Begriff(e) Humans ; Antidotes/therapeutic use ; Fomepizole ; Ethanol ; Renal Dialysis/methods ; Glycolates ; Ethylene Glycol ; Poisoning/therapy
Chemische Substanzen Antidotes ; Fomepizole (83LCM6L2BY) ; Ethanol (3K9958V90M) ; glycolic acid (0WT12SX38S) ; Glycolates ; Ethylene Glycol (FC72KVT52F)
Sprache Englisch
Erscheinungsdatum 2023-02-10
Erscheinungsland England
Dokumenttyp Systematic Review ; Journal Article
ZDB-ID 2041406-7
ISSN 1466-609X ; 1364-8535
ISSN (online) 1466-609X
ISSN 1364-8535
DOI 10.1186/s13054-022-04227-2
Signatur
Zs.A 5517: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang